Rinvoq 30 mg/1 (Upadacitinib TABLET, EXTENDED RELEASE) 30 mg/1

Rinvoq 30 mg is an extended-release tablet used to manage inflammatory conditions. This medication, containing upadacitinib, is designed for oral administration and is manufactured by AbbVie Inc.

Strength

30 mg/1

Pack Size

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2310-30)

Manufacturer / TM Owner

AbbVie Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rinvoq 30 mg is primarily used to help manage symptoms of inflammatory conditions. This medication is often prescribed to reduce inflammation and improve quality of life for individuals dealing with chronic inflammatory disorders. What is Rinvoq 30 mg used for? It is commonly utilized in the treatment of conditions that involve persistent inflammation, aiming to alleviate discomfort and enhance daily functioning.

Side Effects

Common effects of Rinvoq 30 mg may include mild to moderate gastrointestinal discomfort, headaches, and fatigue. Some individuals might experience changes in appetite or mild dizziness. These effects can vary among users and are not exhaustive; always consult a healthcare provider for personalized advice.

Precautions & Warnings

Rinvoq 30 mg should be handled with care, following the prescribed dosage and administration guidelines. It is important to store this medication in a cool, dry place away from direct sunlight. Individuals with known allergies to upadacitinib or similar compounds should avoid using this medication.

Avoid Interactions

Rinvoq 30 mg may interact with certain medications, including those that affect the immune system or metabolism. Alcohol and other substances that alter liver function should be avoided while using this medication. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

Rinvoq 30 mg is used to manage symptoms of inflammatory conditions, helping to reduce inflammation and improve quality of life.

Rinvoq 30 mg is an extended-release tablet designed for oral administration. Follow your healthcare provider's instructions for proper use.

Common effects may include gastrointestinal discomfort, headaches, and fatigue. Individual experiences can vary.

Rinvoq 30 mg may interact with certain medications. Always consult your healthcare provider before combining it with other treatments.

Rinvoq 30 mg may be available from licensed online pharmacies. Ensure you purchase from a reputable source.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.